461 related articles for article (PubMed ID: 18834953)
21. Epigenetic biomarkers in colorectal cancer diagnostics.
Rawson JB; Bapat B
Expert Rev Mol Diagn; 2012 Jun; 12(5):499-509. PubMed ID: 22702366
[TBL] [Abstract][Full Text] [Related]
22. Detection of DNA methylation changes in body fluids.
Liloglou T; Field JK
Adv Genet; 2010; 71():177-207. PubMed ID: 20933129
[TBL] [Abstract][Full Text] [Related]
23. Mining methylation for early detection of common cancers.
Brena RM; Plass C; Costello JF
PLoS Med; 2006 Dec; 3(12):e479. PubMed ID: 17194184
[TBL] [Abstract][Full Text] [Related]
24. Role of epigenetic events in chemical carcinogenesis--a justification for incorporating epigenetic evaluations in cancer risk assessment.
Koturbash I; Beland FA; Pogribny IP
Toxicol Mech Methods; 2011 May; 21(4):289-97. PubMed ID: 21495867
[TBL] [Abstract][Full Text] [Related]
25. Cancer. Developing molecular biomarkers for cancer.
Ransohoff DF
Science; 2003 Mar; 299(5613):1679-80. PubMed ID: 12637728
[No Abstract] [Full Text] [Related]
26. DNA methylation profiling in acute myeloid leukemia: from recent technological advances to biological and clinical insights.
Claus R; Plass C; Armstrong SA; Bullinger L
Future Oncol; 2010 Sep; 6(9):1415-31. PubMed ID: 20919827
[TBL] [Abstract][Full Text] [Related]
27. The emerging role of epigenetics in urological cancers.
Ramachandran K; Soloway MS; Singal R; Manoharan M
Can J Urol; 2007 Jun; 14(3):3535-41. PubMed ID: 17594743
[TBL] [Abstract][Full Text] [Related]
28. Molecular markers for cancer prognosis and treatment: have we struck gold?
Nowsheen S; Aziz K; Panayiotidis MI; Georgakilas AG
Cancer Lett; 2012 Dec; 327(1-2):142-52. PubMed ID: 22120674
[TBL] [Abstract][Full Text] [Related]
29. Epigenetic biomarkers and breast cancer: cause for optimism.
Visvanathan K; Sukumar S; Davidson NE
Clin Cancer Res; 2006 Nov; 12(22):6591-3. PubMed ID: 17121875
[No Abstract] [Full Text] [Related]
30. New perspectives on folate transport in relation to alcoholism-induced folate malabsorption--association with epigenome stability and cancer development.
Hamid A; Wani NA; Kaur J
FEBS J; 2009 Apr; 276(8):2175-91. PubMed ID: 19292860
[TBL] [Abstract][Full Text] [Related]
31. Molecular detection of gene mutations and methylation abnormalities: applications in solid tumor diagnosis.
Kraus A; Schuermann M
Expert Rev Mol Diagn; 2002 Mar; 2(2):97-108. PubMed ID: 11962346
[TBL] [Abstract][Full Text] [Related]
32. Predicting favourable prognosis of urothelial carcinoma: gene expression and genome profiling.
van der Kwast TH; Bapat B
Curr Opin Urol; 2009 Sep; 19(5):516-21. PubMed ID: 19553819
[TBL] [Abstract][Full Text] [Related]
33. Genome-epigenome interactions in cancer.
Brena RM; Costello JF
Hum Mol Genet; 2007 Apr; 16 Spec No 1():R96-105. PubMed ID: 17613554
[TBL] [Abstract][Full Text] [Related]
34. Mass spectrometry-based "omics" technologies in cancer diagnostics.
Zhang X; Wei D; Yap Y; Li L; Guo S; Chen F
Mass Spectrom Rev; 2007; 26(3):403-31. PubMed ID: 17405143
[TBL] [Abstract][Full Text] [Related]
35. Epigenetic biomarkers in lung cancer.
Liloglou T; Bediaga NG; Brown BR; Field JK; Davies MP
Cancer Lett; 2014 Jan; 342(2):200-12. PubMed ID: 22546286
[TBL] [Abstract][Full Text] [Related]
36. [Epigenetics-related diseases and analytic methods].
Soejima H
Rinsho Byori; 2009 Aug; 57(8):769-78. PubMed ID: 19764412
[TBL] [Abstract][Full Text] [Related]
37. Emerging promise of epigenetics and DNA methylation for the diagnosis and management of women's cancers.
Jones A; Lechner M; Fourkala EO; Kristeleit R; Widschwendter M
Epigenomics; 2010 Feb; 2(1):9-38. PubMed ID: 22122746
[TBL] [Abstract][Full Text] [Related]
38. Oncogenomics: prospects for the future.
Sakatani T; Onyango P
Expert Rev Anticancer Ther; 2003 Dec; 3(6):891-901. PubMed ID: 14686710
[TBL] [Abstract][Full Text] [Related]
39. DNA methylation markers predict outcome in node-positive, estrogen receptor-positive breast cancer with adjuvant anthracycline-based chemotherapy.
Hartmann O; Spyratos F; Harbeck N; Dietrich D; Fassbender A; Schmitt M; Eppenberger-Castori S; Vuaroqueaux V; Lerebours F; Welzel K; Maier S; Plum A; Niemann S; Foekens JA; Lesche R; Martens JW
Clin Cancer Res; 2009 Jan; 15(1):315-23. PubMed ID: 19118060
[TBL] [Abstract][Full Text] [Related]
40. Epigenetic targets in cancer epidemiology.
Dumitrescu RG
Methods Mol Biol; 2009; 471():457-67. PubMed ID: 19109794
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
